摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin

中文名称
——
中文别名
——
英文名称
3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin
英文别名
3-(4-Methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazine;3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazine
3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin化学式
CAS
——
化学式
C8H7N7
mdl
——
分子量
201.19
InChiKey
PKLLPDHVNKPPFP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    73.8
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin异丙硫醇三乙胺 作用下, 以 乙腈 为溶剂, 反应 4.0h, 以53%的产率得到6-(isopropylthio)-3-(4-methyl-1H-imidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazine
    参考文献:
    名称:
    3-胍基-6-R-咪唑并[1,2-b]-和6-胍基-3-R-[1,2,4]三唑并[4,3-b][1,2]的合成及生物活性,4,5]四嗪
    摘要:
    研究了唑并环化的 [1,2,4,5] 四嗪与胍的反应。使用亲核取代方法合成了新的 3-胍基咪唑并 [1,2-b]-和 6-胍基 [1,2,4] 三唑并 [4,3-b] [1,2,4,5] 四嗪。揭示了具有高抗菌和抗糖化活性的化合物。
    DOI:
    10.1007/s11172-018-2332-z
  • 作为产物:
    描述:
    3-(2,2-dimethoxyethylamino)-6-(4-methylimidazol-1-yl)-1,2,4,5-tetrazine 在 溶剂黄146 作用下, 以83%的产率得到3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin
    参考文献:
    名称:
    3-取代咪唑并[1,2-b][1,2,4,5]四嗪的合成及抗真菌活性
    摘要:
    合成了许多含有唑基、氨基吡啶基和烷氧基取代基的新型 3-取代咪唑并[1,2-b][1,2,4,5]四嗪。研究了这些化合物对导致皮肤及其附属物(头发、指甲)和酵母样真菌念珠菌的菌丝体亲人类和动物性皮肤真菌(毛癣菌、小孢子菌和表皮癣菌)的生物活性。
    DOI:
    10.1007/s11172-015-1124-y
点击查看最新优质反应信息

文献信息

  • Synthesis and biological activity of 3-guanidino-6-R-imidazo[1,2-b]- and 6-guanidino-3-R-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazines
    作者:R. I. Ishmetova、N. K. Ignatenko、A. V. Korotina、I. N. Ganebnykh、P. A. Slepukhin、V. A. Babkova、N. A. Gerasimova、N. P. Evstigneeva、N. V. Zilberberg、N. V. Kungurov、G. L. Rusinov、A. A. Spasov、O. N. Chupakhin
    DOI:10.1007/s11172-018-2332-z
    日期:2018.11
    reaction of azoloannulated [1,2,4,5]tetrazines with guanidine was studied. New 3-guanidinoimidazo[1,2-b]- and 6-guanidino[1,2,4]triazolo[4,3-b] [1,2,4,5]tetrazines were synthesized using the nucleophilic substitution methodology. Compounds with high antibacterial and antiglycation activity were revealed.
    研究了唑并环化的 [1,2,4,5] 四嗪与胍的反应。使用亲核取代方法合成了新的 3-胍基咪唑并 [1,2-b]-和 6-胍基 [1,2,4] 三唑并 [4,3-b] [1,2,4,5] 四嗪。揭示了具有高抗菌和抗糖化活性的化合物。
  • Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines
    作者:Dmitry A. Maslov、Anna V. Korotina、Kirill V. Shur、Alexey A. Vatlin、Olga B. Bekker、Svetlana G. Tolshchina、Rashida I. Ishmetova、Nina K. Ignatenko、Gennady L. Rusinov、Valery N. Charushin、Valery N. Danilenko
    DOI:10.1016/j.ejmech.2019.05.081
    日期:2019.9
    tuberculosis strains urge the need to develop anti-TB drugs with a novel mechanism of action. We describe synthesis of 22 novel imidazo[1,2-b][1,2,4,5]tetrazine derivatives with different substituents at C(3) and C(6) positions, and their antimycobacterial activity in vitro. 8 compounds show activity as potential serine/threonine protein kinase (STPK) inhibitors in M. smegmatis aphVIII+ test-system, which
    结核病(TB)最近已成为传染病中的主要杀手。具有多种药物和广泛耐药性的结核分枝杆菌菌株促使人们需要开发具有新颖作用机制的抗结核药物。我们描述了22种新型咪唑并[1,2- b ] [1,2,4,5]四嗪衍生物的合成,这些衍生物在C(3)和C(6)位置具有不同的取代基,并在体外具有抗分枝杆菌活性。8种化合物在耻垢分枝杆菌aphVIII +测试系统中显示出作为潜在的丝氨酸/苏氨酸蛋白激酶(STPK)抑制剂的活性,这是此类的特征。5种活性最高的STPK抑制剂中的3种化合物对结核分枝杆菌H37Rv具有显着的最小抑菌浓度1微克/毫升。我们能够获得对4种化合物有抗药性的耻垢分枝杆菌mc2 155突变体,并表明它们与其他药物没有交叉耐药性,但在这4种咪唑并[1,2- b ] [1,2]中具有共同的耐药机制。,4,5]四嗪。化合物3h似乎是最有前途的,结合了预期的STPK抑制剂活性,结核分枝杆菌的最低MIC和耐药突变体出现的频率较低。
  • Synthesis and antifungal activity of 3-substituted imidazo[1,2-b][1,2,4,5]tetrazines
    作者:R. I. Ishmetova、N. K. Ignatenko、I. A. Belyaninova、S. G. Tolshchina、A. V. Korotina、P. A. Slepukhin、N. P. Evstigneeva、N. V. Zil’berberg、P. G. Amineva、N. V. Kungurov、G. L. Rusinov、O. N. Chupakhin
    DOI:10.1007/s11172-015-1124-y
    日期:2015.9
    A number of new 3-substituted imidazo[1,2-b][1,2,4,5]tetrazines containing azolyl, aminopyridyl, and alkoxyl substituents was synthesized. These compounds were studied for the biological activity against mycelial anthropophilic and zoophilous dermatophyte fungi (Trichophyton, Microsporum and Epidermophyton), causing diseases of skin and its appendages (hair, nails), and yeast-like fungi Candida.
    合成了许多含有唑基、氨基吡啶基和烷氧基取代基的新型 3-取代咪唑并[1,2-b][1,2,4,5]四嗪。研究了这些化合物对导致皮肤及其附属物(头发、指甲)和酵母样真菌念珠菌的菌丝体亲人类和动物性皮肤真菌(毛癣菌、小孢子菌和表皮癣菌)的生物活性。
查看更多

同类化合物

米托唑胺 氰基替莫唑胺 替莫唑胺 N-[4-(2-氟苯甲酰)-1,3-二甲基-1H-吡唑-5-基]-N-甲基苯酰胺 3-(2H3)甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N,N-二甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-4-氧代-3H-咪唑并(5,1-d)-1,2,3,5-四嗪-8-羧酸 3,4-二氢-3-甲基-4-氧代咪唑并[5,1-D]-1,2,3,5-四嗪-8-甲酰胺酸 3-cyclohexyl-8-(pyrrolidinocarbonyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-cyclohexyl-8-(piperidinocarbonyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-cyclohexyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazin-8-N-methylcarboxamide ethyl 3-cyclohexyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylate 3-cyclohexyl-8-(morpholinocarbonyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one S-n-butyl 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carbothioate 3-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(isopropylthio)-7-phenylimidazo[1,2-b][1,2,4,5]tetrazine 8-(morpholinocarbonyl)-3-(p-tolyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 4-oxo-3-(p-tolyl)imidazo[5,1-d][1,2,3,5]tetrazin-8-N-methylcarboxamide ethyl 4-oxo-3-(p-tolyl)imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylate 8-(piperidinocarbonyl)-3-(p-tolyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3,8-dimethylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-acetyl-3-methylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(4-methylimidazol-1-yl)imidazo[1,2-b][1,2,4,5]tetrazin 3-methyl-4-oxo-N-(sulfamoyloxy)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-methyl-4-oxo-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide N,N,3-trimethyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide methyl 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carbimidothioate hydroiodide N,3-dimethyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide n-octyl 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylate 3-[2-(2-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-ylcarbamoyl}-1-methylimidazol-4-ylcarbamoyl)-1-methylimidazol-4-yl]-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-(5-{5-[2-(dimethylamino)ethylcarbamoyl]-1-methyl-pyrrol-3-ylcarbamoyl}-1-methylpyrrol-3-yl)-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide hexyl 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylate n-butyl 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylate 3-(2-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-ylcarbamoyl}-1-methylimidazol-4-yl)-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-yl}-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 8-carbamoyl-3-(2-trimethylsilylethoxy)methylimidazo<5,1-d>-1,2,3,5-tetrazin-4(3H)-one nor-temozolomide ethyl 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylate 8-carbamoyl-3-trimethylsilylmethylimidazo<5,1-d>-1,2,3,5-tetrazin-4(3H)-one Temozolomide hydrochloride methyl 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylate [3-N-11C,13C-methyl]temozolomide [4-11C-carbonyl]temozolomide [3-N-11C-methyl]temozolomide N-(2,2-dimethoxyethyl)-3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboximidamide hydroiodide 3-(p-chlorophenyl)-8-(piperidinocarbonyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(morpholinocarbonyl)-3-phenylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(propylthio)imidazo[1,2-b][1,2,4,5]tetrazine Imidazo[5,1-d][1,2,3,5]tetrazine 3-(2-(N-(4-fluorophenyl)-N-methylamino)ethyl)-4-oxo-3H,4H-imidazo[1,5-d][1,2,3,5]tetrazine-8-carboxamide